» Articles » PMID: 28837060

Synthesis and Characterization of Tissue Plasminogen Activator-Functionalized Superparamagnetic Iron Oxide Nanoparticles for Targeted Fibrin Clot Dissolution

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2017 Aug 25
PMID 28837060
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Superparamagnetic iron oxide nanoparticles (SPIONs) have attracted great attention in many biomedical fields and are used in preclinical/experimental drug delivery, hyperthermia and medical imaging. In this study, biocompatible magnetite drug carriers, stabilized by a dextran shell, were developed to carry tissue plasminogen activator (tPA) for targeted thrombolysis under an external magnetic field. Different concentrations of active tPA were immobilized on carboxylated nanoparticles through carbodiimide-mediated amide bond formation. Evidence for successful functionalization of SPIONs with carboxyl groups was shown by Fourier transform infrared spectroscopy. Surface properties after tPA immobilization were altered as demonstrated by dynamic light scattering and ζ potential measurements. The enzyme activity of SPION-bound tPA was determined by digestion of fibrin-containing agarose gels and corresponded to about 74% of free tPA activity. Particles were stored for three weeks before a slight decrease in activity was observed. tPA-loaded SPIONs were navigated into thrombus-mimicking gels by external magnets, proving effective drug targeting without losing the protein. Furthermore, all synthesized types of nanoparticles were well tolerated in cell culture experiments with human umbilical vein endothelial cells, indicating their potential utility for future therapeutic applications in thromboembolic diseases.

Citing Articles

Citrate-Coated Iron Oxide Nanoparticles Facilitate Endothelialization of Left Ventricular Assist Device Impeller for Improved Antithrombogenicity.

Haritz J, Pflaum M, Guntner H, Katsirntaki K, Hegermann J, Hehnen F Adv Sci (Weinh). 2024; 12(6):e2408976.

PMID: 39707689 PMC: 11809402. DOI: 10.1002/advs.202408976.


Nanomaterials for stroke diagnosis and treatment.

Liu Y, Li J, Guo H, Fang C, Yang Q, Qin W iScience. 2024; 27(11):111112.

PMID: 39502285 PMC: 11536039. DOI: 10.1016/j.isci.2024.111112.


Magnetic Nanoparticles Mediated Thrombolysis-A Review.

Zhang B, Jiang X IEEE Open J Nanotechnol. 2023; 4:109-132.

PMID: 38111792 PMC: 10727495. DOI: 10.1109/ojnano.2023.3273921.


Electrospun Magnetic Nanofiber Mats for Magnetic Hyperthermia in Cancer Treatment Applications-Technology, Mechanism, and Materials.

Mamun A, Sabantina L Polymers (Basel). 2023; 15(8).

PMID: 37112049 PMC: 10143376. DOI: 10.3390/polym15081902.


Advances in biotechnology and clinical therapy in the field of peripheral nerve regeneration based on magnetism.

Fan Z, Wen X, Ding X, Wang Q, Wang S, Yu W Front Neurol. 2023; 14:1079757.

PMID: 36970536 PMC: 10036769. DOI: 10.3389/fneur.2023.1079757.


References
1.
Hlady V, Buijs J, Jennissen H . Methods for studying protein adsorption. Methods Enzymol. 1999; 309:402-29. PMC: 2664293. DOI: 10.1016/s0076-6879(99)09028-x. View

2.
Lueshen E, Venugopal I, Soni T, Alaraj A, Linninger A . Implant-Assisted Intrathecal Magnetic Drug Targeting to Aid in Therapeutic Nanoparticle Localization for Potential Treatment of Central Nervous System Disorders. J Biomed Nanotechnol. 2015; 11(2):253-61. DOI: 10.1166/jbn.2015.1907. View

3.
Unterweger H, Subatzus D, Tietze R, Janko C, Poettler M, Stiegelschmitt A . Hypericin-bearing magnetic iron oxide nanoparticles for selective drug delivery in photodynamic therapy. Int J Nanomedicine. 2015; 10:6985-96. PMC: 4648594. DOI: 10.2147/IJN.S92336. View

4.
Poller J, Zaloga J, Schreiber E, Unterweger H, Janko C, Radon P . Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake. Int J Nanomedicine. 2017; 12:3207-3220. PMC: 5402883. DOI: 10.2147/IJN.S132369. View

5.
Chen J, Yang P, Ma Y, Tu S, Lu Y . Targeted delivery of tissue plasminogen activator by binding to silica-coated magnetic nanoparticle. Int J Nanomedicine. 2012; 7:5137-49. PMC: 3463402. DOI: 10.2147/IJN.S36197. View